T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RSPP
1751
DELISTED
RSP Permian, Inc.
RSPP
| $853K | ﹤0.01% |
24,445
+75
| +0.3% | +$2.42K |
|
1752
Horace Mann Educators
HMN
$2.09B
| $842K | ﹤0.01% |
24,910
| – | – |
|
|
IRCP
1753
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
| $838K | ﹤0.01% |
93,459
-12,885
| -12% | -$115K |
|
|
PEI
1754
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $834K | ﹤0.01% |
2,591
-613
| -19% | -$203K |
|
1755
MSC Industrial Direct
MSM
$6.67B
| $833K | ﹤0.01% |
11,809
+11
| +0.1% | +$816 |
|
1756
United Bankshares
UBSI
$6.66B
| $832K | ﹤0.01% |
22,190
+10
| +0% | +$377 |
|
1757
PBF Energy
PBF
$8.81B
| $828K | ﹤0.01% |
34,811
+4,000
| +13% | +$115K |
|
|
TCF
1758
DELISTED
TCF Financial Corporation
TCF
| $820K | ﹤0.01% |
64,832
-1,097,870
| -94% | -$14.5M |
|
1759
Credit Acceptance
CACC
$5.99B
| $818K | ﹤0.01% |
4,419
-1,301
| -23% | -$238K |
|
|
SVU
1760
DELISTED
SUPERVALU Inc.
SVU
| $812K | ﹤0.01% |
24,585
+5,229
| +27% | +$179K |
|
|
RPT
1761
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $808K | ﹤0.01% |
41,227
-15,449
| -27% | -$280K |
|
1762
H.B. Fuller
FUL
$3.24B
| $804K | ﹤0.01% |
18,270
+280
| +2% | +$12.6K |
|
1763
Insperity
NSP
$1.92B
| $803K | ﹤0.01% |
20,800
+1,200
| +6% | +$38.8K |
|
|
SFR
1764
DELISTED
Starwood Waypoint Homes
SFR
| $803K | ﹤0.01% |
26,403
-11,197
| -30% | -$298K |
|
1765
Adeia
ADEA
$3.16B
| $799K | ﹤0.01% |
98,620
+12,852
| +15% | +$104K |
|
|
MBFI
1766
DELISTED
MB Financial Corp
MBFI
| $797K | ﹤0.01% |
21,967
| – | – |
|
1767
Integra LifeSciences
IART
$1.35B
| $796K | ﹤0.01% |
19,960
-6,180
| -24% | -$222K |
|
1768
Hallador Energy
HNRG
$743M
| $794K | ﹤0.01% |
171,912
+51,733
| +43% | +$234K |
|
|
LTC
1769
LTC Properties
LTC
$2.1B
| $793K | ﹤0.01% |
15,338
+28
| +0.2% | +$1.33K |
|
1770
Manulife Financial
MFC
$72.6B
| $793K | ﹤0.01% |
58,300
| – | – |
|
1771
Northwest Bancshares
NWBI
$2.31B
| $792K | ﹤0.01% |
53,379
| – | – |
|
1772
Hecla Mining
HL
$11.9B
| $788K | ﹤0.01% |
154,500
-8,800
| -5% | -$35.6K |
|
1773
Viasat
VSAT
$12B
| $788K | ﹤0.01% |
11,039
+1,529
| +16% | +$111K |
|
1774
Tenet Healthcare
THC
$21.5B
| $786K | ﹤0.01% |
28,446
-152,529
| -84% | -$4.51M |
|
1775
Cerus
CERS
$572M
| $785K | ﹤0.01% |
125,800
+19,300
| +18% | +$115K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.